AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare company Medibank Private Limited today reported significant growth in operations for the fiscal year ended 30 June 2018. Groupâs operating profit increased 9.7% to $548.8 million in FY18, which is largely attributable to Health Insuranceâs operating profit increase of $38.1 million during the year.
But net profit attributable to shareholders declined by 1.0% to $445.1 million at the back of lower net investment income. There has been 1.6% growth in revenue with increase in Health Insurance premium revenue and Medibank Health revenue. Earnings per share was 16.2 cps.
[optin-monster-shortcode id="wxhmli4jjedneglg1trq"]
The board declared fully franked final dividend of 7.20 cents per share, payable on 27 September 2018. With this, total dividend for FY18 becomes 12.70 cents per share, up 5.8% on FY17.
Medibankâs stock moved down 2.208% to $3.100, on 24 August 2018, as company reported slump in their FY18 profit.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a companyâs prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkineâs team of analysts bought you handpicked report for âTop 25 Dividend Stocks For 2018.â
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
